Scientists Cite Advances on Two Kinds of Cancer

âThis is a phenomenal example of finding the right patient and the right drug very early on,â said Dr. Pasi A. Janne of the Dana-Farber Cancer Institute in Boston, who was involved in the trial that is cited by the following report.
clipped from www.nytimes.com

CHICAGO — Using two opposite strategies, scientists say they have made significant progress in taming two of the most intractable types of cancer.


One approach, highly focused on specific types of tumors, shrank them significantly in 57 percent of patients with a lung cancer marked by a specific genetic abnormality.


Even though the clinical trial was small (just 82 people, with no control group), the results were considered so striking for such sick patients that the study will be featured Sunday at the main session of the annual meeting of the American Society of Clinical Oncology here.

 blog it

Comments

Popular posts from this blog

#MCL?▶ #SocialCurrentSee

#StemCell #Transplant▶ #SocialCurrentSee®

Canswer♥Worth®▶ #SocialCurrentSee®

Privacy Notice

Privacy Notice: The sites and blogs of ALTACITIES conform to these PRIVACY PRACTICES.